These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 19808330)

  • 1. The effects of vasodilators in pulmonary hypertension: pulmonary vascular or peripheral vascular?
    Rich S
    Circ Heart Fail; 2009 Mar; 2(2):145-50. PubMed ID: 19808330
    [No Abstract]   [Full Text] [Related]  

  • 2. Should patients with pulmonary hypertension and increased pulmonary resistance be treated with vasodilators?
    Rich S
    Cardiovasc Clin; 1990; 21(1):265-74; discussion 275-6. PubMed ID: 2199052
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of sildenafil on pulmonary hypertension and exercise tolerance in severe cystic fibrosis-related lung disease.
    Montgomery GS; Sagel SD; Taylor AL; Abman SH
    Pediatr Pulmonol; 2006 Apr; 41(4):383-5. PubMed ID: 16479610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vasodilators in "primary" pulmonary hypertension?].
    Morpurgo M
    G Ital Cardiol; 1990 Feb; 20(2):123-25. PubMed ID: 2328865
    [No Abstract]   [Full Text] [Related]  

  • 5. [Primary pulmonary hypertension. An overview with special reference to risk-benefit analysis of therapy].
    Schilling W
    Z Erkr Atmungsorgane; 1991; 177(3):117-34. PubMed ID: 1808861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central role of peripheral mechanisms in exercise intolerance in chronic heart failure: the muscle hypothesis.
    Piepoli M
    Cardiologia; 1998 Sep; 43(9):909-17. PubMed ID: 9859605
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chronic pulmonary hypertension--causes, effects, therapy].
    Hombach V; Wieshammer S; Hetzel M
    Klin Anasthesiol Intensivther; 1995; 47():221-40. PubMed ID: 7715176
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of vasodilators on pulmonary hypertension].
    Uotani K; Kanamori K; Fujimura M; Mifune J; Taga K; Shimizu M; Hifumi S; Takahashi Y; Azuma H; Tanaka T
    Kokyu To Junkan; 1986 Sep; 34(9):977-83. PubMed ID: 3786964
    [No Abstract]   [Full Text] [Related]  

  • 9. Unpredictable response to vasodilator therapy in primary pulmonary hypertension.
    Schmiedt MI; Shettigar UR; Siddique M; Barbier G; Bialow M; Carranza S
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):435-40. PubMed ID: 9726697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What might be learned from acute pulmonary vasodilator testing in portopulmonary hypertension?
    Swanson KL
    Liver Transpl; 2007 Nov; 13(11):1498-9. PubMed ID: 17969195
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of pulmonary hypertension with vasodilation agents].
    Tschopp JM
    Schweiz Rundsch Med Prax; 1984 Jun; 73(25):789-91. PubMed ID: 6473980
    [No Abstract]   [Full Text] [Related]  

  • 12. Vasodilators ineffective in secondary pulmonary hypertension.
    Dash H; Ballentine N; Zelis R
    N Engl J Med; 1980 Oct; 303(18):1062-3. PubMed ID: 7421904
    [No Abstract]   [Full Text] [Related]  

  • 13. Hope in primary pulmonary hypertension.
    Reeves JT
    N Engl J Med; 1980 Jan; 302(2):112-3. PubMed ID: 7350416
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vasodilator therapy in pulmonary arterial hypertension of unknown cause (primary)].
    Lupi Herrera E
    Arch Inst Cardiol Mex; 1982; 52(3):189-90. PubMed ID: 7114962
    [No Abstract]   [Full Text] [Related]  

  • 15. Vasodilators in pulmonary hypertension.
    Peacock A
    Thorax; 1993 Dec; 48(12):1196-9. PubMed ID: 8303622
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulmonary vasodilators.
    Siobal MS
    Respir Care; 2007 Jul; 52(7):885-99. PubMed ID: 17594732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repetitive dosing of intravenous levosimendan improves pulmonary hemodynamics in patients with pulmonary hypertension: results of a pilot study.
    Kleber FX; Bollmann T; Borst MM; Costard-Jäckle A; Ewert R; Kivikko M; Petterson T; Pohjanjousi P; Sonntag S; Wikström G
    J Clin Pharmacol; 2009 Jan; 49(1):109-15. PubMed ID: 18981240
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapy of pulmonary hypertension: the evolution from vasodilators to antiproliferative agents.
    Rubin LJ
    Am J Respir Crit Care Med; 2002 Nov; 166(10):1308-9. PubMed ID: 12421739
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vasodilator agents in pulmonary hypertension].
    Farga V
    Rev Med Chil; 1987 Sep; 115(9):902-4. PubMed ID: 3506285
    [No Abstract]   [Full Text] [Related]  

  • 20. Vasodilators in patients with chronic obstructive pulmonary disease and pulmonary hypertension: not ready for prime time!
    Humbert M; Simonneau G
    Am J Respir Crit Care Med; 2010 Feb; 181(3):202-3. PubMed ID: 20093654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.